EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chronic Hepatitis B in the Transplant Setting: A 30-Year Experience in a Single Tertiary Italian Center

Francesco Paolo Russo iD, Sara Battistella iD, Alberto Zanetto iD, Martina Gambato iD, Alberto Ferrarese iD, Giacomo Germani, Marco Senzolo, Claudia Mescoli, Salvatore Piano, Francesco Enrico D'Amico iD, Alessandro Vitale iD, Enrico Gringeri iD und 4 weitere

Viruses · 2025

DOI: 10.3390/v17040454 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Francesco Paolo Russo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Multivisceral Transplant Unit, Azienda Ospedale-Università di Padova, 35125 Padua, Italy. Hauptthemen laut MEDLINE: Liver Transplantation, Hepatitis B, Chronic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatitis B virus (HBV) remains a leading etiology for liver transplantation (LT). In a large cohort of HBsAg-positive patients, this study evaluates long-term patient and graft survival after LT over the past 30 years while analyzing trends and outcomes following waiting list (WL) inclusion over the last 15 years.

Methods

HBsAg-positive patients who underwent transplantation between 1991 and 2020 and were waitlisted from 2006 to 2020 at Padua Hospital were included in the analysis. Patients were stratified according to hepatitis delta virus (HDV) coinfection, transplant indication (decompensated cirrhosis vs. hepatocellular carcinoma (HCC)), and WL inclusion period.

Results

Among 321 HBsAg-positive LT recipients (31.5% HDV-coinfected, 46.4% HCC), 1-year and 5-year patient/graft survival rates were 87.6%/86.7% and 82.6%/82.2%, respectively. From 2006 to 2020, 284 HBsAg-positive patients were waitlisted (32.6% HDV-coinfected), with a significantly higher prevalence of HCC compared to non-HBV patients (p = 0.008). High-barrier nucleos(t)ide analogues (hbNUCs) significantly reduced mortality (p = 0.041) and improved survival post-WL inclusion (p = 0.007). Survival rates were consistent regardless of LT indication, HDV coinfection, or WL inclusion period. Post-transplant prophylaxis predominantly involved immunoglobulins (HBIG) + NUCs, resulting in only two cases of HBV reactivation, both clinically inconsequential.

Conclusions

Over the past 30 years, HBV has remained a consistent indication for LT at our center. Thanks to hbNUCs, WL outcomes have improved and HCC has become the main indication for LT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationHepatitis B, ChronicHumansMaleFemaleMiddle AgedItalyTertiary Care CentersCarcinoma, HepatocellularAdultLiver NeoplasmsCoinfectionHepatitis B Surface AntigensAgedGraft SurvivalHepatitis B virusWaiting ListsHepatitis Delta VirusRetrospective StudiesHepatitis DLiver Cirrhosis

Stichwörter der Autor:innen

HBIGHBVHBV prophylaxisHDVNUCsliver transplantation

Substanzen

Hepatitis B Surface Antigens

Autor:innen und Institutionen

  • Gastroenterology and Multivisceral Transplant Unit, Azienda Ospedale-Università di Padova, 35125 Padua, Italy.
  • Department of Surgery, Oncology and Gastroenterology, University of Padua, 35125 Padua, Italy.
  • Department of Medicine, (Pathology Section), University Hospital of Padua, 35125 Padua, Italy.
  • Unit of Internal Medicine and Hepatology, Department of Medicine, University of Padua, 35125 Padua, Italy.
  • General Surgery 2, Azienda Ospedale-Università di Padova, 35125 Padua, Italy.
  • Anaesthesia and Intensive Care, Department of Medicine, Padua University Hospital, 35125 Padua, Italy.

ORCID-Profile: Francesco Paolo Russo, Sara Battistella, Alberto Zanetto, Martina Gambato, Alberto Ferrarese, Francesco Enrico D'Amico, Alessandro Vitale, Enrico Gringeri, Umberto Cillo, Patrizia Burra

Zitieren

APA

Russo, F. P., Battistella, S., Zanetto, A., Gambato, M., Ferrarese, A., Germani, G., Senzolo, M., Mescoli, C., Piano, S., D'Amico, F. E., Vitale, A., Gringeri, E., Feltracco, P., Angeli, P., Cillo, U., & Burra, P. (2025). Chronic Hepatitis B in the Transplant Setting: A 30-Year Experience in a Single Tertiary Italian Center. Viruses. https://doi.org/10.3390/v17040454

Vancouver

Russo FP, Battistella S, Zanetto A, Gambato M, Ferrarese A, Germani G, et al. Chronic Hepatitis B in the Transplant Setting: A 30-Year Experience in a Single Tertiary Italian Center. Viruses. 2025. doi:10.3390/v17040454

BibTeX
@article{Russo2025,
  author = {Russo, Francesco Paolo and Battistella, Sara and Zanetto, Alberto and Gambato, Martina and Ferrarese, Alberto and Germani, Giacomo and Senzolo, Marco and Mescoli, Claudia and Piano, Salvatore and D'Amico, Francesco Enrico and Vitale, Alessandro and Gringeri, Enrico and Feltracco, Paolo and Angeli, Paolo and Cillo, Umberto and Burra, Patrizia},
  title = {Chronic Hepatitis B in the Transplant Setting: A 30-Year Experience in a Single Tertiary Italian Center},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17040454}
}
Kostenlos starten →